Grants: Ophthalmic Genetics
Page Content
An IPSC Cell-Based Model of Macular Degeneration for Drug Discovery
- Wahlin Karl, Ph.D.
- California Institute for Regenerative Medicine
Complement Factor H Mutant Pluripotent Stem Cells to Model Early Onset Macular Degeneration and their Application in Drug Discovery
- Wahlin Karl, Ph.D.
- BrightFocus Foundation
Microenvironment Based Optimization of Retinal Induction Using Crispr-Cas9 Reporter Pluripotent Stem Cells as an Expandable Source of Retinal Progenitors and Photoreceptors
- Wahlin Karl, Ph.D.
- California Institute for Regenerative Medicine
Modeling Photoreceptor Development and Disease Using Human Pluripotent Stem Cells
Show additional content areas below
ContentA1